Foliowing extracapsular cataract and posterior chamber implant surgery the sequential recovery of the blood-aqueous barrier was measured by anterior segment fluorophotometry. Postoperatively 49 (69.0%) out of 71 eyes (71 patients) had recovered at a uniform rate, re-establishing a normal blood-aqueous barrier by the end of the three-month study. In these eyes recovery of the blood-aqueous barrier was unaffected by the use of preoperative indomethacin, the surgeon, the type of section, or the type of fixation of the implant. In eyes recovering normaily after cataract surgery the rate of recovery of the bloodaqueous barrier can be expressed by a in the equation a=(y-b)/x, in which y is the logarithm of the anterior chamber fluorescence, x is the time after surgery, and b is a constant for each patient which is the anterior chamber fluorescence measured immediately after surgery. This normal rate of recovery provides a baseline from which to assess surgical technique or postoperative medication.
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The results of cataract surgery and visual recovery vary in the postoperative period, but in the long term they are highly successful, with vision of 6/12 or better in over 95% of patients. Failure in otherwise normal eyes is related to poor placement of the implant, residual soft lens matter, posterior capsular thickening, uveitis from surgical trauma or chronic chafing of uveal tissue, low grade infection, or cystoid macular oedema. Breakdown of the blood-ocular barriers (both the blood-aqueous barrier anteriorly and the blood-retinal barrier posteriorly) may occur in these conditions and has been implicated in the pathogenesis of many of these problems.' 2 Anterior segment fluorophotometry is an objective, reproducible, and simple technique3 for measuring the degree and duration of breakdown of the blood-aqueous barrier (BAB) and was used in this study to follow the sequential recovery of the BAB in 71 patients for the first three months after surgery, with the aim of studying the factors that influence the immediate postoperative recovery of the eye following routine extracapsular cataract extraction and insertion of a posterior chamber implant. Time in days Figure 1 Scatter graph ofACfluorescence with timefor all 49 eyes which recovered uneventfully. There are high levels immediately after surgery, whichfall during thefirst month. At three months 69% ofeyes had levels ofAC fluorescence below 400 ng/ml (pg/l).
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Results
The trend was for high leakage of fluorescent metabolites into the AC during the first postoperative week, with a steady fall in AC fluorescence during the following three months. By this time 49 eyes out of the total of 71 (69 0%) had normal levels of AC fluorescence below 400 ng/ ml (tg/l) (Fig 1) . Of the remaining eyes 14 (19-7%) still had high levels at three months and 8 (11-3%) recovered initially, but subsequently had high levels. Typical examples are illustrated in Figure 2 . The reasons for failure to recover the BAB in these patients are the subject of a subsequent report.
Sequential fluorophotometry measurements of the 49 eyes which had re-established intact blood-aqueous barriers were interpreted by calculating the rate ofrecovery ofeach patient. This was represented mathematically by the gradient a of the line y=ax+b, where y was the AC fluorescence on a logarithmic scale and x the time in days after surgery. There was a good correlation between the AC fluorescence and time for surgery when the best-fit linear graph was drawn through the four fluorophotometry measurements for each of the 49 patients. The mean The first two groups compared were those with sulcus placed implants but operated on by two different surgeons (Fig 3) . Group A (nine eyes by surgeon 1) had a limbal section and group B (11 eyes by surgeon 2) had a corneal section. There was no statistically significant difference between the two groups (Mann-Whitney U test, p>0. 1). There was a tendency for the eyes with limbal sections to have slightly higher levels of AC fluorescence initially, but at three months there was no significant difference between them. Apart from the type of section, both surgeons used similar techniques and the eyes showed comparable postoperative progress, final visual results, and final recovery of the bloodaqueous barrier, so all 20 eyes from these two surgeons were grouped as the 'sulcus group'.
The sulcus group and those with bag fixation ofthe implant (15 eyes by surgeons 1 and 2) were compared (Fig 4) . Best fit curves show similar rates of recovery, falling to within 400 ng/ml ([tg/l), indicating recovery of the BAB by three months. The eyes with implants in the capsular bag had lower leakages initially (p>O0 1) but by three months they had a slightly higher AC fluorescence than those with sulcus fixed implants, but this was not statistically significant (Mann-Whitney U test, p>0. 1). Figure 5 shows the results of those with bag fixed implants, one group had no indomethacin (15 eyes by surgeons 1 and 2), and the other was treated with topical indomethacin preoperatively (11 Analysis of the individual slopes of recovery did not show any evidence that the rate of recovery varied between the 49 eyes. The mean gradient was -0 004 (SD 0003). That is, the eyes that recovered to normal all recovered at the same rate, the duration to recovery being solely determined by the degree ofinitial damage to the BAB (Fig 6) .
Discussion
In cataract surgery the blood-aqueous barrier, which consists of the endothelium of iris blood vessels and the non-pigmented ciliary epithelium, is susceptible to surgical trauma at the time of operation, and this damage can either lead to recovery quickly or be prolonged for weeks or months after surgery. Several authors have looked at recovery of the BAB after cataract surgery, but this is the only sequential study of recovery of a cohort of patients with time. This report looks at those eyes (69%) which recovered a normal BAB within three months and at whether the speed of recovery was influenced by factors such as a limbal or corneal section, position of the implant in the bag or ciliary sulcus, the use of preoperative topical indomethacin, or the operating surgeon. We found no difference in the rate of recovery of the BAB in the first three months postoperatively from any of these factors.
Recovery of the BAB has been followed by iris angiography, which gives a qualitative assessment,4 but In order to calculate indices of permeability or diffusion assumptions have to be made, firstly, about fluorescein metabolism and its pharmacokinetics in the blood and in the eye (there are varying amounts of free and protein bound fluorescein and fluorescein glucuronide); and, secondly, the eye is taken as standard with spherical surfaces, a given area of iris and a given AC volume. These physiological formulae are not always valid in real patients, particularly in the inflamed eye. We took the plateau levels of AC fluorescence which we have done in previous studies3 (Ambrose VMG, et al, personal communication). They are simple to measure, with a reproducibility of 87% (comparing measurements on the same subjects on two separate visits, the nested analysis of variance showed an intrapair correlation coefficient of r=0-87 1), and they provide an absolute measure ofthe degree of breakdown of the BAB which can be compared between patients.
In eyes with uncomplicated surgery we found that the BAB recovered rapidly during the first six weeks, and at three months a normal intact blood-aqueous barrier was demonstrated by stable plateau levels of AC fluorescence in 69-0% of eyes. But 31% of eyes failed to re-establish normal BABs. These included 19'7% (14 eyes) which still had high AC levels at three months and 11 3% (eight eyes) which appeared to recover normally at first but then had abnormally high levels. Interestingly, this proportion correlates well with the histopathological findings by Champion et al" who found that 34% of postmortem eyes examined between eight months and 10 years after implant insertion showed evidence ofcyclitis and iritis, and it suggests that inflammatory processes underlie failure to recover BAB function in most cases.
Other workers have also looked at the duration of breakdown and influence of implant position 12 looked at eyes with uncomplicated extracapsular cataract surgery (average follow-up of one year after operation) and found that for posterior chamber implants those with sulcus fixation leaked more than those with bag fixation. They also showed that eyes with bag fixed implants had comparable leakage to eyes without implants. After a longer followup of three years there was no difference in the leakage between aphakic eyes and those with bag or sulcus implants. These results imply that the advantage of bag to sulcus fixation is the prevention of uveal chafing or erosion, which becomes obvious or important only on medium to long term follow-up.
In any study comparing the advantages of bag to sulcus fixation of the implant in the posterior chamber it is necessary to know that the implant is actually where the surgeon intended to put it. In reality it is extremely difficult to assess this accurately, particularly when 7 mm diameter implants are used, as it is not easy to be certain that the implant is in the bag. It Miyake"2 performed fluorophotometry (after giving intravenous fluorescein) four weeks after cataract surgery by phacoemulsification and showed less AC fluorescence in those patients treated with topical indomethacin postoperatively, but at two years there was no difference between the treated and placebo groups. Araie et al8 used fluorophotometry to measure the transfer coefficient of eyes after intracapsular cataract surgery and found that topical indomethacin inhibited barrier disruption at six days after surgery. These results suggest that indomethacin has a beneficial early action but has less influence in the long term. A possible explanation is that the effects of prostaglandin inhibitors are secondary to maintaining pupillary dilatation (which they do very effectively). That is, they may well act by reducing surgical trauma and manipulation to the iris at the time of operation rather than by direct action on the BAB.
In addition to finding a similar recovery of breakdown of the BAB in all the eyes we have found a uniform rate of return to normality in those eyes that had recovered their BAB by three months independently of surgeon, type of section, placement of implant, or use of preoperative indomethacin. If fluorophotometry is plotted on a logarithmic scale against time, the rate of recovery can be described by the equation a=(y-b)/x, where y is the AC fluorescence and x is the time after surgery. This implies that eyes with higher levels of BAB dysfunction immediately after surgery will recover at the same rate as those with less damage but will take longer to do so, provided this 'normal' recovery process is not interfered with by secondary inflammatory processes. One measurement should be necessary to enable prediction of the duration of recovery of the BAB and to provide a baseline against which changes in surgical technique or postoperative medication could be assessed (Fig 6) . 
